1050611-00-1 Usage
General Description
(3-cyanooxetan-3-yl)acetic acid ethyl ester is a chemical compound with the formula C8H9NO3. It is an ester of (3-cyanooxetan-3-yl)acetic acid, which is a cyclic oxetane derivative. (3-cyanooxetan-3-yl)acetic acid ethyl ester has potential applications as a building block in organic synthesis, particularly in the development of pharmaceuticals and agrochemicals. It is also used in the research and development of new materials and chemical processes. Additionally, its unique structure makes it an interesting target for studies in organic and medicinal chemistry, as it may exhibit unique reactivity and biological properties. Overall, (3-cyanooxetan-3-yl)acetic acid ethyl ester is a versatile chemical compound with a wide range of potential applications in various fields of science and industry.
Check Digit Verification of cas no
The CAS Registry Mumber 1050611-00-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,5,0,6,1 and 1 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1050611-00:
(9*1)+(8*0)+(7*5)+(6*0)+(5*6)+(4*1)+(3*1)+(2*0)+(1*0)=81
81 % 10 = 1
So 1050611-00-1 is a valid CAS Registry Number.
1050611-00-1Relevant articles and documents
Macrocyclic MCL-1 inhibitors and methods of use
-
Paragraph 0896, (2019/02/28)
The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).
COMPOUNDS FOR TREATING VIRAL INFECTIONS
-
Page/Page column 87-88, (2008/12/08)
The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection.
